KristineBPattersonMD

Infectious Disease • Little Rock, AR

HIV/AIDS Medicine, STD Medicine

Associate Professor

Join to view full profile

Dr. Patterson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Patterson's full profile

Already have an account?

Office
UAMS Medical Center
4110 Outpatient Circle Outpatient Center, Second Floor, Suite 2P
Little Rock, AR 72205
Phone+1 501-603-1616

Education & Training

University of North Carolina HospitalsFellowship, Infectious Disease, 2000 - 2003
University of Texas Medical Branch HospitalsResidency, Internal Medicine, 1996 - 1999
Emory University School of MedicineClass of 1996

Certifications & Licensure

AR State Medical License 2019 - 2025
NY State Medical License 2015 - 2019
NC State Medical License 2000 - 2016
TX State Medical License 1999 - 2000

Clinical Trials

Sex, Aging and Antiretroviral Pharmacokinetics Start of enrollment: 2008 Mar 01
Completed
The Effect of Pregnancy on the Pharmacokinetics of the Kaletra Tablet Start of enrollment: 2007 Jan 01
Completed
Phase 1
A Pilot Study to Characterize the Pharmacokinetics of Raltegravir in the Cervicovaginal Fluids of HIV-infected Women Start of enrollment: 2008 Aug 01
Completed
Study in Healthy Males to Measure Maraviroc in Blood, Saliva, Seminal Fluid, and Rectal Tissue Start of enrollment: 2008 May 01
Completed
Phase 1
Study in Healthy Males to Measure Darunavir and Etravirine in Blood, Seminal Fluid, and Rectal Tissue Start of enrollment: 2009 Jul 01
Completed
Phase 1
IMPAACT 1077HS: Examining Benefits of HAART Continuation in Postpartum Women Start of enrollment: 2010 Jan 01
Completed
Phase 4
Evaluating the Pharmacokinetics of 400 mg Oral Dose of Raltegravir in HIV-Infected Pre-Menopausal Women Start of enrollment: 2009 Jul 01
Completed
The Effect of Pregnancy on the PK of Isentress®: A Longitudinal Investigation in the Second and Third Trimesters Start of enrollment: 2010 Nov 01
Withdrawn
Dose-Proportionality and Intra-Individual Variability of Intracellular TFV-DP and FTC-TP in Healthy Volunteers Start of enrollment: 2011 Jan 01
Completed
Phase 1
Study to Characterize the Pharmacokinetics of Raltegravir in the Gastrointestinal (GI) Tract of Healthy Male Volunteers Start of enrollment: 2011 Apr 01
Completed
Phase 1
Single Dose Truvada in HIV-negative Men and Women Start of enrollment: 2008 Oct 01
Completed
GSK1349572 Exposure in Blood, Seminal Fluid, and Rectal Fluid and Tissue in Healthy Male Subjects Start of enrollment: 2011 Nov 01
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

10 citations
Postpartum HIV care continuum outcomes in the southeastern USA.
Jane S Chen, Brian W. Pence, Lisa Rahangdale, Kristine B. Patterson, Claire E Farel
AIDS. 2019-03-15
16 citations
Cervicovaginal and Rectal Fluid as a Surrogate Marker of Antiretroviral Tissue Concentration: Implications for Clinical Trial Design.
Mackenzie L. Cottrell, Heather M.A. Prince, Andrew G. Allmon, Katie R. Mollan, Michael G. Hudgens
Journal of Acquired Immune Deficiency Syndromes. 2016-08-15
223 citations
A Translational Pharmacology Approach to Predicting Outcomes of Preexposure Prophylaxis Against HIV in Men and Women Using Tenofovir Disoproxil Fumarate With or Withou...
Mackenzie L. Cottrell, Kuo-Hsiung. Yang, Heather M.A. Prince, Craig Sykes, Nicole White
The Journal of Infectious Diseases. 2016-07-01

Press Mentions

Comparison of Tenofovir Plasma and Tissue Exposure Using a Population Pharmacokinetic Model and Bootstrap: A Simulation Study from Observed DataNovember 8th, 2017

Grant Support

SEX, Aging And Antiretroviral PharmacologyNational Institute Of Allergy And Infectious Diseases2008–2012
Clinical Trial: Sex Differences In Lopinavir/Ritonavir Pharmaco Among HIV-1 MenNational Center For Research Resources2008
Clinical Trial: Sch47690 In Hiv-Infected, Treatment Experienced SubjectsNational Center For Research Resources2008
Clinical Trial: Phase II Study To Compare Twice Daily And Once Daily Therapy AndNational Center For Research Resources2008
Clinical Trial: Aactg 5202 - Phase IIIB Trial Of Open-Label Efavirenz Or AtazanaNational Center For Research Resources2008
Clinical Trial: Aactg 5188 - Phase II Transdermal Contraceptive System In HIV-1National Center For Research Resources2008
CID 0705 - Vaccine Screening RegistryNational Center For Research Resources2008
Sex Differences In Lopinavir/Ritonavir Pharmaco Among HIV-1 Men And WomenNational Center For Research Resources2007
Immunologic And Virologic Differences Between Pre- And Post-Men HIV WomenNational Center For Research Resources2006–2007
Aactg 5202 - Phase IIIB Trial Of Open-Label Efavirenz Or AtazanaviNational Center For Research Resources2006–2007
Aactg 5188 - Phase II Transdermal Contraceptive System In HIV-1 WomenNational Center For Research Resources2006–2007
Sch47690 In Hiv-Infected, Treatment Experienced SubjectsNational Center For Research Resources2005–2007
Phase II Study To Compare Twice Daily And Once Daily Therapy And Self-AdministerNational Center For Research Resources2005–2007
PK Interactions Between Dmpa, Depo-Provera And Selected Protease InhibsNational Center For Research Resources2004–2007
Virologic And Immunologic Changes In Hiv-Infected Women During PostpartumNational Center For Research Resources2006
Phase I/II Trial Of Anti-Hiv Activity Amp;Safety Of Mifepristone (Aactg 5200)National Center For Research Resources2006
Impact Of Therapeutic Drug Monitoring On Virologic Response To A Salvage RegimenNational Center For Research Resources2004–2006
Therapeutic Drug Monitoring On Virologic Response To A Salvage Regimen: AIDSNational Center For Research Resources2005

KristineBPattersonMD

Dr. Patterson is on Doximity

Education & Training

Certifications & Licensure

Clinical Trials

Publications & Presentations

Press Mentions

Grant Support

Viewing the full profile is available to verified healthcare professionals only.